|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Drug therapy of multiple myeloma显示文摘 | Kyle RA Rajkumar SV | 2004 | N Engl J Med2004，351，： | 1 |
| 2 | 显示文摘 | Hanson CA Rajkumar SV | 2000 | Blood2000，96，： | 1 |
| 3 | Prevention of thalidomide - and lenalidomide - associated thrombosis in myeloma 显示文摘 | Palumbo A Rajkumar SV Dimopoulos MA | 2008 | Leukemia2008，22，2： | 1 |
| 4 | Multicenter, random- ized, double-blind, placebo-controlled study of thalidomide显示文摘 | Rajkumar SV Rosiol L Hussein M | 2008 | J Clin Oncol2008，26，13： | 1 |
| 5 | Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance显示文摘 | Rajkumar SV Kyle RA Therneau TM | 2005 | Blood2005，106，3： | 1 |
| 6 | Monoclonal gammopathy of undetermined significance, Waldenstrom macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment 显示文摘 | Rajkumar SV Dispenzieri A Kyle RA | 2006 | Mayo Clin Proc2006，81，5： | 1 |
| 7 | Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma显示文摘 | Stewart AK Rajkumar SV Dimopoulos MA | 2015 | N EnglJ Med2015，372，2： | 1 |
| 8 | Thalidomide as initial therapy for early stage myeloma 显示文摘 | Rajkumar SV Gextz MA lacy MQ | | Leukemia0，17，4： | 1 |
| 9 | Bone marrow angiogenesis in multiple myeloma: closing in on the loop显示文摘 | Molina JR Rajkumar SV | 2003 | Haematologica2003，88，2： | 1 |
| 10 | Proteasome inhibition as a novel therapeutic target in human cancer显示文摘 | Rajkumar SV Richardson PG Hideshima T | 2005 | J Clin Oncol2005，23，3： | 1 |
| 11 | Multiple myeloma:2012 update on diagnosis,risk-stratification,and management显示文摘 | Rajkumar SV | | 0，，01： | 1 |
| 12 | Primary systemic amyloidosis with delayed progression to multiple myeloma显示文摘 | Rajkumar SV Gertz MA Kyle RA | 1998 | Cancer1998，82，8： | 1 |
| 13 | Criteria for diagnosis,staging,risk stratification and response as- sessment of multiple myeloma显示文摘 | Kyle RA Rajkumar SV | 2009 | Leukemia2009，23，： | 1 |
| 14 | Current therapy for multiple myeloma显示文摘 | Rajkumar SV Gerta MA Kyle RA | 2002 | Mayo Clin Proc2002，77，8： | 1 |
| 15 | Progonstic value of bone marrow angiogensis in multiple myeloma显示文摘 | Rajkumar SV leong T Roche PC | 2000 | Clin Cancer Res2000，6，： | 1 |
| 16 | Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance 显示文摘 | Rajkumar SV Kyle RA Therneau TM | 2005 | Blood2005，106，： | 1 |
| 17 | Multiple myeloma:chemotherapy or transplantation in the era of new drugs显示文摘 | Palumbo A Rajkumar SV | 2010 | Eur J Haematol2010，84，5： | 1 |
| 18 | International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma显示文摘 | Rajkumar SV Dimopoulos MA Palumbo A | 2014 | Lancet Oncol2014，15，12： | 1 |
| 19 | International myeloma working group updated criteria for the diagnosis of multiple myeloma 显示文摘 | Rajkumar SV Dimopoulos MA Palumbo A | 2014 | Lancet Oncol2014，15，12： | 1 |
| 20 | Multiple myeloma 显示文摘 | Kyle RA Rajkumar SV | 2004 | N Engl J Med2004，351，18： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员